Lepu Medical Technology (Beijing) Co., Ltd. develops, manufactures, and distributes medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters, Angiocide peripheral cutting balloons, and PeakSheath disposable artery sheath; and cardiovascular products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, fractional flow reserves, and accessories. It also provides digital subtraction angiography systems, such as Vicor-CV Robin C/F digital subtraction angiography systems and Vicor-CV SWIFT medical angiography x-ray systems; congenital heart disease products; cardiac rhythm management products that comprise electrophysiology, pacemakers and leads, and equipment; ECG, patient monitors, and oximeters; home medical equipment, such as oxygen generators, nebulizers, sphygmomanometers, infrared and digital thermometers, measuring instrument, fingerpulse pulse oximeters, and eye massage instruments; critical care products; dialyzers, hemoperfutor, and hemodialysis accessories; in vitro diagnostics comprising hematology, point of care testing, immunoassay, molecular diagnostics, and biochemistry; surgical stapler, endoscopy, and endoscopic ultrasound system; portable, trolley, and veterinary ultrasound products; oncology diagnostics; and orthopedic products. Lepu Medical Technology (Beijing) Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.
Metrics to compare | 300003 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300003PeersSector | |
---|---|---|---|---|
P/E Ratio | 147.2x | 27.3x | −0.6x | |
PEG Ratio | −1.95 | −1.77 | 0.00 | |
Price/Book | 2.2x | 2.5x | 2.6x | |
Price / LTM Sales | 5.8x | 8.2x | 3.3x | |
Upside (Analyst Target) | 5.7% | 24.8% | 39.1% | |
Fair Value Upside | Unlock | 19.5% | 5.4% | Unlock |